Interventional × Ovarian Diseases × Clear all
NCT03562897 2022-07-06

Evaluation of Ocoxin-ViusidĀ® in Advanced or Metastatic Ovarian Epithelial Cancer

Catalysis SL

Phase 2 Completed
40 enrolled